8-K - Replimune Group, Inc. (0001737953) (Filer)
Published . Updated .
8-K - Replimune Group filed an 8-K with the SEC on Oct 28 (a notice of a material company event).
Directly affected
- REPL Replimune Group
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Replimune Group belongs to, so it often moves with news about it.
- AMGN Amgen+19.0% 30d
Amgen is a peer of Replimune Group in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+8.6% 30d
Gilead Sciences is a peer of Replimune Group in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+42.8% 30d
Moderna is a peer of Replimune Group in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-18.3% 30d
argenx SE is a peer of Replimune Group in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Replimune Group in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| REPL | -10.20% | -12.27% | base | +2.38% | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| AMGNNo price data for this ticker | — | — | — | — | — | — | — |
| GILDNo price data for this ticker | — | — | — | — | — | — | — |
| MRNANo price data for this ticker | — | — | — | — | — | — | — |
| ARGXNo price data for this ticker | — | — | — | — | — | — | — |
| RVMDNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-28 AccNo: 0001104659-26-119354 Size: 272 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Replimune Group (REPL) has moved since 28 Oct 2026
| Company | When | Move | Status |
|---|---|---|---|
| Replimune Group (REPL) | that day | +2.38% | still updating |
| Replimune Group (REPL) | three days earlier | -12.27% | final price |
| Replimune Group (REPL) | five days earlier | -10.20% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 36 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 63 days before publication. Filed 5 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $1,001 - $15,000 on 12 Aug 2026. That is 77 days before publication. Filed 2 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 79 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 61 days before publication. Filed 8 Oct 2026. View the filing.
- Scott A Kupor, an executive branch official, sold Revolution Medicines (RVMD), worth $1,001 - $15,000 on 30 Jul 2026. That is 90 days before publication. Filed 30 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Replimune Group (REPL)
Companies mentioned with this story
- REPL Replimune Group
Replimune Group (REPL) is linked, with no stored direction, high confidence in the 28 Oct 2026 story “8-K - Replimune Group, Inc. (0001737953) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> REPL
How “8-K - Replimune Group, Inc. (0001737953) (Filer)” reaches Replimune Group (REPL)
“8-K - Replimune Group, Inc. (0001737953) (Filer)” (28 Oct 2026) reaches Replimune Group (REPL) through this story.
The link for Replimune Group (REPL) is this: SEC 8-K filing -> direct issuer disclosure -> REPL
The price range for Replimune Group (REPL), and the dates in the story
REPL traded between 12.47 and 13.63 across 2 sessions. The latest close on file is 13.02.
How strong the case is around Replimune Group (REPL)
14 out of 100Price not final
“8-K - Replimune Group, Inc. (0001737953) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies. The price is not final yet.